Ancillare – Your Single Source for Clinical Trial Ancillary Supply Chain
Complex studies require a singular focus on Clinical Trial Ancillary Supply Chain (CTASCTM) management. From diagnostic testing and medical equipment, to centrifuges, disposable products, refrigerators, computers, ECG machines, and delivery systems, our industry-leading approach consolidates as many supply chain functions as possible.
Ancillare offers Sponsors a collaborative, consultative, and forward-thinking approach to ancillary supply and equipment management for Phase I-IV clinical trials. Our industry-defining model includes robust Ancillare Clinical Trial Ancillary Supply Chain (CTASC™) programs, which provide:
Global Ancillary Supply & Equipment Capabilities
Protocol Analysis & Planning
Illuminate the supply plan based on your program’s goals and optimize your supply strategy.
Expert Sourcing & Procurement
Maximize your buying power on the purchase of supplies, kits, medical devices, and technical equipment.
Global Storage & Distribution
Leverage our extensive network of depots, saving significantly on storage and shipping costs.
Kitting, Labeling, & Printing
Labeling of supplies, kitting, and printing of multilingual documentation are critical steps, and we ensure they are done right.
Returns, Reclamation, & Disposition
Whether for return, destruction, or resale, we handle all final trial supply material reconciliations and documentation.
Global trade compliance (import/export) and regulatory support are offered on a trial-by-trial and enterprise-level basis.
A Clinical Trial Ancillary Supply Chain (CTASCTM) ensures efficient delivery to sites, avoids multiple shipments and non-compliance issues, and mitigates site delays due to stocking or import/export challenges.
Only Ancillare has a suite of technology solutions custom-built to for the supply chains of clinical research. Our technology provides:
Ancillare is the first and only Life Sciences company dedicated to Clinical Trial Ancillary Supply Chain (CTASCTM) for Phase I-IV clinical research. Ancillare arms Sponsors of global clinical trials with customized, end-to-end supply plans, enabling developers of new therapies to optimize their supply chains using streamlined processes, extensive global buying power, a vast depot network, and proven teams of clinical, procurement, operations, logistics and regulatory experts. Ancillare’s industry-shaping model navigates the complexities of the Clinical Trial Ancillary Supply Chain to reduce both the overall cost and cycle time of clinical trials, and greatly improve operational efficiency across all levels of the value chain.
Ancillare has supported more than 4,000 clinical trials across 200,000 clinical sites over 100 countries with corporate offices in the United States and Europe, and distribution hubs in Argentina, Brazil, Canada, China, Israel, Japan, South Korea, Mexico, Netherlands, Philippines, Russia, Taiwan, and Ukraine.